No Data
Digitalization Achieves Remarkable Results Again! The First ICQCC International Gold Award!
New Data Supporting a New Precision Medicine Approach for ALS Patients With GeNeuro's GNK-301 Presented at the 35th International Symposium on ALS/MND
MediciNova Presents Study Update And Interim Analysis Of Phase 2/3 Clinical Trial Of MN-166 In ALS At The 35th International Symposium On ALS/MND
Express News | Medicinova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of Mn-166 (Ibudilast) in ALS (Combat-ALS Clinical Trial) at the 35TH International Symposium on ALS/Mnd
Alkeus Pharmaceuticals Announces Positive Gildeuretinol Data Will Be Presented During the 12th International FLORetina ICOOR Congress December 5–8 in Florence, Italy
Transposon to Present Results From Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 35th International Symposium on ALS/MND